The final programme, reports, press releases and abstracts from the 22nd International Symposium on ALS/MND, held in Sydney, Australia are available to view and download.
“I’m looking forward to the usual brilliant organisation, great atmosphere and engaging presentations from the world’s leading MND researchers.”
– Dr Chris Gibbons, Delegate and ReCCoB Blogger
Final Programme and Abstracts
Ralph Warren, President of MND Australia and Glen Doyle on behalf of the Gadigal tribe welcomed delegates to the 22nd International Symposium on ALS/MND in Sydney, Australia, organised by the Motor Neurone Disease (MND) Association.
A key speaker at the neuroimaging session was Dr Martin Turner from Oxford University and the Association’s Oxford MND Care Centre. Three years into his groundbreaking research study to identify a new MND ‘biomarker’ he is, arguably, the man to talk about neuroimaging and MND.Headlines from final day of International Symposium
The 22nd International Symposium on ALS/MND has drawn to a close with delegates eager to build on the knowledge shared and to develop the international community’s research and care capability.
The final day of the world’s largest conference dedicated to MND focused on two areas essential to the vision of a world free of MND: clinical trials and disease models.
- Next Chapter of BMAA detective story
- Beauty and the Beast – when misfolded proteins cause havoc
- The season of the gene
- Windows to the brain
- Clinical trial low down, down under
- Changing fashions of MND models
- Final thoughts from Sydney
- Promising news for keeping the motor neurone neighbourhood safe
- *Image kindly provided by Dr Martin Turner, University of Oxford